Fasano, Alfonso http://orcid.org/0000-0001-5346-0180
García-Ramos, Rocío
Gurevich, Tanya
Jech, Robert
Bergmann, Lars
Sanchez-Soliño, Olga
Parra, Juan Carlos
Simu, Mihaela
Clinical trials referenced in this document:
Documents that mention this clinical trial
Levodopa–carbidopa intestinal gel in advanced Parkinson’s disease: long-term results from COSMOS
https://doi.org/10.1007/s00415-023-11615-3
Article History
Received: 31 October 2022
Revised: 17 January 2023
Accepted: 7 February 2023
First Online: 18 February 2023
Declarations
:
: The authors also declare that there are no conflicts of interest relevant to this work.
: All procedures were completed in accord with the ethical standards of the Independent Ethics Committees or Institutional Review Boards of the institution where data were collected.
: Dr. Fasano received research support from Medtronic, Boston Scientific, University of Toronto, Michael J. Fox Foundation for Parkinson’s Research and Dystonia Medical Research Foundation, and honoraria from Abbott, Brainlab, UCB pharma, Medtronic, Novartis, Chiesi, Boston Scientific, AbbVie, Ipsen, and Sunovion for serving as a speaker. Dr. García-Ramos received honoraria for advisor, consultant, and/or speaker engagements from AbbVie, Allergan, Italfarmaco, Merz Pharma, Teva, UCB, and Zambon. Dr. Gurevich was a study investigator, received honoraria from AbbVie, Neuroderm, Medison, Truemed and Teva, research support from Parkinson’s Foundation, University Tel-Aviv and International Movement Disorders Society and travel support from AbbVie, Medison, Medtronic and Allergan. Dr. Jech received honoraria from AbbVie, Medtronic, Ipsen, Allergan, Cardion for consultancies and lectures. Dr. Simu received honoraria for lecturing at symposia and consultancy from AbbVie, AOP Orphan, Boehringer Ingelheim, Krka, Merck, Sanofi, Servier Pharma, Teva, and UCB Pharma. Drs. Bergmann, Sanchez-Soliño, Parra, are employees of AbbVie and may hold stock and/or stock options.
: All procedures of the COSMOS study (NCT03362879) were completed in accordance with the ethical standards of the Independent Ethics Committees or Institutional Review Boards of the institution where data were collected. Written informed consent was obtained by each patient or legal authorized representative prior to any data collection. The authors confirm that the approval of an institutional review board and informed consent were not required for this work, as it consists exclusively of secondary analysis of fully de-identified and publicly available data. We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.